findmyKOL

Reiad Najjar, MD

Basic profile

Cedars-Sinai Medical Center

ORCIDNPI
RegionWest Hollywood, CA · WestSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Reiad Najjar is a Nephrology physician affiliated with Cedars-Sinai Medical Center. OpenAlex indexes 33 publications with 1,109 citations (h-index 18).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
33publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,109citations

Total citations across indexed works.

18h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
9companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

8900 Beverly Blvd # 226
West Hollywood, CA 900482438

Telephone

310-423-2641

Provider last certified this registry record 29 Mar 2024.

View the NPPES registry record

Industry payments

9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    40%
    Corticosteroid19%
    Prednisone100%
    Part D154 patients
    Proton pump inhibitor11.3%
    Pantoprazole Sodium100%
    Part D110 patients

    + 5 more classes in this area

  • Anti-infectives

    24.4%
    Short-acting sulfonamides7.1%
    Sulfamethoxazole-Trimethoprim100%
    Part D93 patients
    Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor7.1%
    Valganciclovir Hcl100%
    Part D97 patients

    + 6 more classes in this area

  • Cardiovascular

    22.6%
    Beta blocker7.6%
    Carvedilol64%Metoprolol Tartrate16%Metoprolol Succinate9%Propranolol Hcl7%Labetalol Hcl5%
    Part D<11 patients
    Calcium channel blocker6.3%
    Nifedipine Er66%Amlodipine Besylate34%
    Part D55 patients

    + 5 more classes in this area

Where care is delivered (Part B)33.2% facility · 66.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”